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Correction
E C Keystone, M C Genovese, L Klareskog, et al. Golimumab, a human antibody to tumour necrosis 
factor α given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrex-
ate therapy: the GO-FORWARD Study. Ann Rheum Dis 2009;68:789-796. Due to a programming error 
pertaining to CRP units used in the DAS28-CRP calculations resulted in data errors. The DAS28-CRP 
values were calculated with CRP in units of mg/dL instead of mg/L and therefore the DAS values in 
Table 1 are incorrect. Please note, the conclusions from the study remain unchanged.
                                                                                                  doi:10.1136/ard.2008.099010corr1
  Group 1 Group 2 Group 3 Group 4 Groups 3 and 4 Combined
DAS28 using CRP  5.458 (4.672 to 6.093) 5.364 (4.683 to 6.236) 5.766 (4.628 to 6.322) 5.393 (4.748 to 6.172)  5.513 (4.721 to 6.271)
The correct DAS values in Table 1 should be published as follows:
  Group 1 Group 2 Group 3 Group 4 Groups 3 and 4 Combined
DAS28 using CRP  4.860 (4.194 to 5.480) 4.803 (4.151 to 5.558) 5.100 (4.060 to 5.651) 4.902 (4.320 to 5.521) 4.931 (4.174 to 5.598)
The DAS values in Table 1 have been published as follows:
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